AbbVie Analysts Increase Their Forecasts After Upbeat Earnings
Portfolio Pulse from Lisa Levin
AbbVie Inc reported better-than-expected Q3 earnings and raised its profit outlook, leading to a 2.8% rise in its shares. Following the announcement, Barclays and Morgan Stanley increased their price targets on AbbVie.
October 30, 2023 | 6:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AbbVie's better-than-expected Q3 earnings and raised profit outlook led to a rise in its shares and increased price targets from Barclays and Morgan Stanley.
AbbVie's better-than-expected earnings and raised profit outlook are positive indicators of the company's performance, which has led to a rise in its share price. This has also prompted Barclays and Morgan Stanley to increase their price targets on the company, indicating a positive outlook for the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100